Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added the term 'Small cell lung carcinoma' in the related terms and a link to the Genetic and Rare Diseases Information Center in the Resources section.
    Difference
    0.1%
    Check dated 2026-03-28T03:15:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-21T00:56:38.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:08:15.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1, which appears to be an internal site version update; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:51:47.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no substantive changes observed to study details or instructions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T15:43:35.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Added a glossary display option and updated metadata labels to show Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the older label Last Update Submitted that met QC Criteria, the No FEAR Act data wording, and the older Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T06:57:38.000Z thumbnail image

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.